Table 1.
Details of the subjects who took part in the experiments. Subjects were either implanted in the UK and tested in Cambridge (UK) or implanted in Denmark and tested in Lyngby (DK). Information regarding the duration of deafness was not available (N.A.) for all listeners
| Listener | Sex | Age | Onset of hearing loss | Implant type | Country | Years of implant use | Duration of deafness |
|---|---|---|---|---|---|---|---|
| AB01 | M | 73 | Post-lingual, progressive | HR90k Advantage/HiFocus MS | UK | 9 | N.A. |
| AB02 | F | 50 | Post-lingual, progressive | HR90k/HiFocus 1J | UK | 10 | 16 |
| AB03 | M | 71 | Post-lingual, progressive | HR90k/HiFocus 1J | UK | 9 | N.A. |
| AB05 | M | 75 | Post-lingual, progressive | HR90k/HiFocus 1J | UK | 7 | 30 |
| AB06 | F | 68 | Peri-lingual, progressive | HR90k/HiFocus 1J | UK | 3 | 25 |
| AB09 | M | 71 | Post-lingual, progressive | HR90K Advantage/HiFocus MS | UK | 4 | N.A. |
| AB13 | M | 78 | Post-lingual, progressive | HR90k/HiFocus 1J | UK | 10 | 10 |
| AB24 | F | 47 | Post-lingual, sudden | HR90k Advantage/HiFocus MS | UK | 1 | 1 |
| AB27 | M | 78 | Post-lingual, progressive | HiRes Ultra/HiFocus ms | UK | 0.5 | 30 |
| S1-DK | F | 27 | Post-lingual, progressive | HR90k/HiFocus 1J | DK | 4 | 4 |
| S2-DK | F | 60 | Post-lingual, progressive | HR90k/ HiFocus 1J | DK | 8 | N.A. |